STAAR Surgical surpasses 3 million cumulative ICL sales globally

STAAR SURGICAL CO

More than 3 million Implantable Collamer Lenses (ICLs) sold worldwide; EVO ICL accounts for ~2.5 million of that total.
CEO Tom Frinzi cites EVO ICL as next logical step in refractive innovation with clear patient outcome differentiators.
Milestone reflects growing adoption for myopia, astigmatism, and presbyopia correction via minimally invasive procedure.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.